APO Research
Talk to an analyst

APO RESEARCH · REPORT

Plasmid DNA (pDNA)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasmid DNA (pDNA) Market Outlook and Growth Opportunities 2026

27 December 2025200 pages

Choose your research edition.

Industry ResearchPlasmid DNA (pDNA) Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasmid DNA (pDNA) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasmid DNA (pDNA) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasmid DNA (pDNA) Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasmid DNA (pDNA) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Plasmid DNA (pDNA) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasmid DNA (pDNA) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasmid DNA (pDNA) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasmid DNA (pDNA) market include GenScript Biotech, Xpress Biologics, WuXi Advanced Therapies, Waisman Biomanufacturing, Takara Bio, Synbio Technologies, Recipharm, Patheon and GenScript ProBio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasmid DNA (pDNA) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasmid DNA (pDNA) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasmid DNA (pDNA) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasmid DNA (pDNA) market.

Plasmid DNA (pDNA) Segment by Company

GenScript Biotech

Xpress Biologics

WuXi Advanced Therapies

Waisman Biomanufacturing

Takara Bio

Synbio Technologies

Recipharm

Patheon

GenScript ProBio

Eurogentec

Esco Aster

Creative Biolabs

Charles River Laboratories

Catalent Biologics

Biovian

Andelyn Biosciences

Aldevron

Akron Biotech

AGC Biologics

Plasmid DNA (pDNA) Segment by Type

Research Grade Plasmid DNA

Commercial Grade Plasmid DNA

Plasmid DNA (pDNA) Segment by Application

Cancers

Viral Infections

Inherited Disorders

Other

Plasmid DNA (pDNA) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasmid DNA (pDNA) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasmid DNA (pDNA) key companies, revenue, market share, and recent developments.

3. To split the Plasmid DNA (pDNA) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasmid DNA (pDNA) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasmid DNA (pDNA) significant trends, drivers, influence factors in global and regions.

6. To analyze Plasmid DNA (pDNA) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA (pDNA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA (pDNA) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA (pDNA).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasmid DNA (pDNA) industry.

Chapter 3: Detailed analysis of Plasmid DNA (pDNA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasmid DNA (pDNA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasmid DNA (pDNA) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasmid DNA (pDNA) Industry Trends Table 2. Plasmid DNA (pDNA) Industry Drivers Table 3. Plasmid DNA (pDNA) Industry Opportunities and Challenges Table 4. Plasmid DNA (pDNA) Industry Restraints Table 5. Global Plasmid DNA (pDNA) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasmid DNA (pDNA) Revenue Share by Company (2021-2026) Table 7. Global Plasmid DNA (pDNA) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasmid DNA (pDNA) Key Company Manufacturing Base & Headquarters Table 9. Global Plasmid DNA (pDNA) Company, Product Type & Application Table 10. Global Plasmid DNA (pDNA) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasmid DNA (pDNA) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Research Grade Plasmid DNA Table 15. Significant Companies of Commercial Grade Plasmid DNA Table 16. Global Plasmid DNA (pDNA) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Plasmid DNA (pDNA) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Plasmid DNA (pDNA) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Plasmid DNA (pDNA) Sales Value Share by Type (2021-2026) Table 20. Global Plasmid DNA (pDNA) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cancers Table 22. Significant Companies of Viral Infections Table 23. Significant Companies of Inherited Disorders Table 24. Significant Companies of Other Table 25. Global Plasmid DNA (pDNA) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Plasmid DNA (pDNA) Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Plasmid DNA (pDNA) Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Plasmid DNA (pDNA) Sales Value Share by Application (2021-2026) Table 29. Global Plasmid DNA (pDNA) Sales Value Share by Application (2027-2032) Table 30. Global Plasmid DNA (pDNA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Plasmid DNA (pDNA) Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Plasmid DNA (pDNA) Sales Value Share by Region (2021-2026) Table 33. Global Plasmid DNA (pDNA) Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Plasmid DNA (pDNA) Sales Value Share by Region (2027-2032) Table 35. Global Plasmid DNA (pDNA) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Plasmid DNA (pDNA) Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Plasmid DNA (pDNA) Sales Value Market Share by Country (2021-2026) Table 38. Global Plasmid DNA (pDNA) Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Plasmid DNA (pDNA) Sales Value Market Share by Country (2027-2032) Table 40. GenScript Biotech Company Information Table 41. GenScript Biotech Business Overview Table 42. GenScript Biotech Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. GenScript Biotech Plasmid DNA (pDNA) Product Portfolio Table 44. GenScript Biotech Recent Development Table 45. Xpress Biologics Company Information Table 46. Xpress Biologics Business Overview Table 47. Xpress Biologics Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Xpress Biologics Plasmid DNA (pDNA) Product Portfolio Table 49. Xpress Biologics Recent Development Table 50. WuXi Advanced Therapies Company Information Table 51. WuXi Advanced Therapies Business Overview Table 52. WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio Table 54. WuXi Advanced Therapies Recent Development Table 55. Waisman Biomanufacturing Company Information Table 56. Waisman Biomanufacturing Business Overview Table 57. Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio Table 59. Waisman Biomanufacturing Recent Development Table 60. Takara Bio Company Information Table 61. Takara Bio Business Overview Table 62. Takara Bio Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Takara Bio Plasmid DNA (pDNA) Product Portfolio Table 64. Takara Bio Recent Development Table 65. Synbio Technologies Company Information Table 66. Synbio Technologies Business Overview Table 67. Synbio Technologies Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Synbio Technologies Plasmid DNA (pDNA) Product Portfolio Table 69. Synbio Technologies Recent Development Table 70. Recipharm Company Information Table 71. Recipharm Business Overview Table 72. Recipharm Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Recipharm Plasmid DNA (pDNA) Product Portfolio Table 74. Recipharm Recent Development Table 75. Patheon Company Information Table 76. Patheon Business Overview Table 77. Patheon Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Patheon Plasmid DNA (pDNA) Product Portfolio Table 79. Patheon Recent Development Table 80. GenScript ProBio Company Information Table 81. GenScript ProBio Business Overview Table 82. GenScript ProBio Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GenScript ProBio Plasmid DNA (pDNA) Product Portfolio Table 84. GenScript ProBio Recent Development Table 85. Eurogentec Company Information Table 86. Eurogentec Business Overview Table 87. Eurogentec Plasmid DNA (pDNA) Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Eurogentec Plasmid DNA (pDNA) Product Portfolio Table 89. Eurogentec Recent Development Table 90. Esco Aster Company Information Table 91. Esco Aster Business Overview Table 92. Esco Aster Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Esco Aster Plasmid DNA (pDNA) Product Portfolio Table 94. Esco Aster Recent Development Table 95. Creative Biolabs Company Information Table 96. Creative Biolabs Business Overview Table 97. Creative Biolabs Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Creative Biolabs Plasmid DNA (pDNA) Product Portfolio Table 99. Creative Biolabs Recent Development Table 100. Charles River Laboratories Company Information Table 101. Charles River Laboratories Business Overview Table 102. Charles River Laboratories Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio Table 104. Charles River Laboratories Recent Development Table 105. Catalent Biologics Company Information Table 106. Catalent Biologics Business Overview Table 107. Catalent Biologics Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Catalent Biologics Plasmid DNA (pDNA) Product Portfolio Table 109. Catalent Biologics Recent Development Table 110. Biovian Company Information Table 111. Biovian Business Overview Table 112. Biovian Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Biovian Plasmid DNA (pDNA) Product Portfolio Table 114. Biovian Recent Development Table 115. Andelyn Biosciences Company Information Table 116. Andelyn Biosciences Business Overview Table 117. Andelyn Biosciences Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio Table 119. Andelyn Biosciences Recent Development Table 120. Aldevron Company Information Table 121. Aldevron Business Overview Table 122. Aldevron Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Aldevron Plasmid DNA (pDNA) Product Portfolio Table 124. Aldevron Recent Development Table 125. Akron Biotech Company Information Table 126. Akron Biotech Business Overview Table 127. Akron Biotech Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Akron Biotech Plasmid DNA (pDNA) Product Portfolio Table 129. Akron Biotech Recent Development Table 130. AGC Biologics Company Information Table 131. AGC Biologics Business Overview Table 132. AGC Biologics Plasmid DNA (pDNA) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. AGC Biologics Plasmid DNA (pDNA) Product Portfolio Table 134. AGC Biologics Recent Development Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Plasmid DNA (pDNA) Product Image Figure 2. Global Plasmid DNA (pDNA) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasmid DNA (pDNA) Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasmid DNA (pDNA) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Research Grade Plasmid DNA Image Figure 8. Commercial Grade Plasmid DNA Image Figure 9. Global Plasmid DNA (pDNA) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Plasmid DNA (pDNA) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Plasmid DNA (pDNA) Sales Value Share by Type (2021-2032) Figure 12. Cancers Image Figure 13. Viral Infections Image Figure 14. Inherited Disorders Image Figure 15. Other Image Figure 16. Global Plasmid DNA (pDNA) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Plasmid DNA (pDNA) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Plasmid DNA (pDNA) Sales Value Share by Application (2021-2032) Figure 19. Global Plasmid DNA (pDNA) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Plasmid DNA (pDNA) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Plasmid DNA (pDNA) Sales Value (2021-2032) & (US$ Million) Figure 22. North America Plasmid DNA (pDNA) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Plasmid DNA (pDNA) Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Plasmid DNA (pDNA) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Plasmid DNA (pDNA) Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Plasmid DNA (pDNA) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Plasmid DNA (pDNA) Sales Value (2021-2032) & (US$ Million) Figure 28. South America Plasmid DNA (pDNA) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Plasmid DNA (pDNA) Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Plasmid DNA (pDNA) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade Plasmid DNA
  • Commercial Grade Plasmid DNA
Applications
  • Cancers
  • Viral Infections
  • Inherited Disorders
  • Other
Companies covered
  • GenScript Biotech
  • Xpress Biologics
  • WuXi Advanced Therapies
  • Waisman Biomanufacturing
  • Takara Bio
  • Synbio Technologies
  • Recipharm
  • Patheon
  • GenScript ProBio
  • Eurogentec
  • Esco Aster
  • Creative Biolabs
  • Charles River Laboratories
  • Catalent Biologics
  • Biovian
  • Andelyn Biosciences
  • Aldevron
  • Akron Biotech
  • AGC Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasmid DNA (pDNA) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasmid DNA (pDNA) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasmid DNA (pDNA) Market Dynamics
  1. 2.1 Plasmid DNA (pDNA) Industry Trends
  2. 2.2 Plasmid DNA (pDNA) Industry Drivers
  3. 2.3 Plasmid DNA (pDNA) Industry Opportunities and Challenges
  4. 2.4 Plasmid DNA (pDNA) Industry Restraints
3 Plasmid DNA (pDNA) Market by Company
  1. 3.1 Global Plasmid DNA (pDNA) Company Revenue Ranking in 2025
  2. 3.2 Global Plasmid DNA (pDNA) Revenue by Company (2021-2026)
  3. 3.3 Global Plasmid DNA (pDNA) Company Ranking (2024-2026)
  4. 3.4 Global Plasmid DNA (pDNA) Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasmid DNA (pDNA) Company Product Type and Application
  6. 3.6 Global Plasmid DNA (pDNA) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasmid DNA (pDNA) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasmid DNA (pDNA) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasmid DNA (pDNA) Market by Type
  1. 4.1 Plasmid DNA (pDNA) Type Introduction
  2. 4.1.1 Research Grade Plasmid DNA
  3. 4.1.2 Commercial Grade Plasmid DNA
  4. 4.2 Global Plasmid DNA (pDNA) Sales Value by Type
  5. 4.2.1 Global Plasmid DNA (pDNA) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Plasmid DNA (pDNA) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Plasmid DNA (pDNA) Sales Value Share by Type (2021-2032)
5 Plasmid DNA (pDNA) Market by Application
  1. 5.1 Plasmid DNA (pDNA) Application Introduction
  2. 5.1.1 Cancers
  3. 5.1.2 Viral Infections
  4. 5.1.3 Inherited Disorders
  5. 5.1.4 Other
  6. 5.2 Global Plasmid DNA (pDNA) Sales Value by Application
  7. 5.2.1 Global Plasmid DNA (pDNA) Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Plasmid DNA (pDNA) Sales Value by Application (2021-2032)
  9. 5.2.3 Global Plasmid DNA (pDNA) Sales Value Share by Application (2021-2032)
6 Plasmid DNA (pDNA) Regional Value Analysis
  1. 6.1 Global Plasmid DNA (pDNA) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasmid DNA (pDNA) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasmid DNA (pDNA) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasmid DNA (pDNA) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasmid DNA (pDNA) Sales Value (2021-2032)
  7. 6.3.2 North America Plasmid DNA (pDNA) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasmid DNA (pDNA) Sales Value (2021-2032)
  10. 6.4.2 Europe Plasmid DNA (pDNA) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasmid DNA (pDNA) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasmid DNA (pDNA) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasmid DNA (pDNA) Sales Value (2021-2032)
  16. 6.6.2 South America Plasmid DNA (pDNA) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasmid DNA (pDNA) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasmid DNA (pDNA) Sales Value Share by Country, 2025 VS 2032
7 Plasmid DNA (pDNA) Country-level Value Analysis
  1. 7.1 Global Plasmid DNA (pDNA) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasmid DNA (pDNA) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasmid DNA (pDNA) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasmid DNA (pDNA) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasmid DNA (pDNA) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasmid DNA (pDNA) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasmid DNA (pDNA) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GenScript Biotech
  2. 8.1.1 GenScript Biotech Company Information
  3. 8.1.2 GenScript Biotech Business Overview
  4. 8.1.3 GenScript Biotech Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GenScript Biotech Plasmid DNA (pDNA) Product Portfolio
  6. 8.1.5 GenScript Biotech Recent Developments
  7. 8.2 Xpress Biologics
  8. 8.2.1 Xpress Biologics Company Information
  9. 8.2.2 Xpress Biologics Business Overview
  10. 8.2.3 Xpress Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xpress Biologics Plasmid DNA (pDNA) Product Portfolio
  12. 8.2.5 Xpress Biologics Recent Developments
  13. 8.3 WuXi Advanced Therapies
  14. 8.3.1 WuXi Advanced Therapies Company Information
  15. 8.3.2 WuXi Advanced Therapies Business Overview
  16. 8.3.3 WuXi Advanced Therapies Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WuXi Advanced Therapies Plasmid DNA (pDNA) Product Portfolio
  18. 8.3.5 WuXi Advanced Therapies Recent Developments
  19. 8.4 Waisman Biomanufacturing
  20. 8.4.1 Waisman Biomanufacturing Company Information
  21. 8.4.2 Waisman Biomanufacturing Business Overview
  22. 8.4.3 Waisman Biomanufacturing Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Waisman Biomanufacturing Plasmid DNA (pDNA) Product Portfolio
  24. 8.4.5 Waisman Biomanufacturing Recent Developments
  25. 8.5 Takara Bio
  26. 8.5.1 Takara Bio Company Information
  27. 8.5.2 Takara Bio Business Overview
  28. 8.5.3 Takara Bio Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takara Bio Plasmid DNA (pDNA) Product Portfolio
  30. 8.5.5 Takara Bio Recent Developments
  31. 8.6 Synbio Technologies
  32. 8.6.1 Synbio Technologies Company Information
  33. 8.6.2 Synbio Technologies Business Overview
  34. 8.6.3 Synbio Technologies Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Synbio Technologies Plasmid DNA (pDNA) Product Portfolio
  36. 8.6.5 Synbio Technologies Recent Developments
  37. 8.7 Recipharm
  38. 8.7.1 Recipharm Company Information
  39. 8.7.2 Recipharm Business Overview
  40. 8.7.3 Recipharm Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Recipharm Plasmid DNA (pDNA) Product Portfolio
  42. 8.7.5 Recipharm Recent Developments
  43. 8.8 Patheon
  44. 8.8.1 Patheon Company Information
  45. 8.8.2 Patheon Business Overview
  46. 8.8.3 Patheon Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Patheon Plasmid DNA (pDNA) Product Portfolio
  48. 8.8.5 Patheon Recent Developments
  49. 8.9 GenScript ProBio
  50. 8.9.1 GenScript ProBio Company Information
  51. 8.9.2 GenScript ProBio Business Overview
  52. 8.9.3 GenScript ProBio Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GenScript ProBio Plasmid DNA (pDNA) Product Portfolio
  54. 8.9.5 GenScript ProBio Recent Developments
  55. 8.10 Eurogentec
  56. 8.10.1 Eurogentec Company Information
  57. 8.10.2 Eurogentec Business Overview
  58. 8.10.3 Eurogentec Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eurogentec Plasmid DNA (pDNA) Product Portfolio
  60. 8.10.5 Eurogentec Recent Developments
  61. 8.11 Esco Aster
  62. 8.11.1 Esco Aster Company Information
  63. 8.11.2 Esco Aster Business Overview
  64. 8.11.3 Esco Aster Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Esco Aster Plasmid DNA (pDNA) Product Portfolio
  66. 8.11.5 Esco Aster Recent Developments
  67. 8.12 Creative Biolabs
  68. 8.12.1 Creative Biolabs Company Information
  69. 8.12.2 Creative Biolabs Business Overview
  70. 8.12.3 Creative Biolabs Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Creative Biolabs Plasmid DNA (pDNA) Product Portfolio
  72. 8.12.5 Creative Biolabs Recent Developments
  73. 8.13 Charles River Laboratories
  74. 8.13.1 Charles River Laboratories Company Information
  75. 8.13.2 Charles River Laboratories Business Overview
  76. 8.13.3 Charles River Laboratories Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Charles River Laboratories Plasmid DNA (pDNA) Product Portfolio
  78. 8.13.5 Charles River Laboratories Recent Developments
  79. 8.14 Catalent Biologics
  80. 8.14.1 Catalent Biologics Company Information
  81. 8.14.2 Catalent Biologics Business Overview
  82. 8.14.3 Catalent Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Catalent Biologics Plasmid DNA (pDNA) Product Portfolio
  84. 8.14.5 Catalent Biologics Recent Developments
  85. 8.15 Biovian
  86. 8.15.1 Biovian Company Information
  87. 8.15.2 Biovian Business Overview
  88. 8.15.3 Biovian Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biovian Plasmid DNA (pDNA) Product Portfolio
  90. 8.15.5 Biovian Recent Developments
  91. 8.16 Andelyn Biosciences
  92. 8.16.1 Andelyn Biosciences Company Information
  93. 8.16.2 Andelyn Biosciences Business Overview
  94. 8.16.3 Andelyn Biosciences Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Andelyn Biosciences Plasmid DNA (pDNA) Product Portfolio
  96. 8.16.5 Andelyn Biosciences Recent Developments
  97. 8.17 Aldevron
  98. 8.17.1 Aldevron Company Information
  99. 8.17.2 Aldevron Business Overview
  100. 8.17.3 Aldevron Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Aldevron Plasmid DNA (pDNA) Product Portfolio
  102. 8.17.5 Aldevron Recent Developments
  103. 8.18 Akron Biotech
  104. 8.18.1 Akron Biotech Company Information
  105. 8.18.2 Akron Biotech Business Overview
  106. 8.18.3 Akron Biotech Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Akron Biotech Plasmid DNA (pDNA) Product Portfolio
  108. 8.18.5 Akron Biotech Recent Developments
  109. 8.19 AGC Biologics
  110. 8.19.1 AGC Biologics Company Information
  111. 8.19.2 AGC Biologics Business Overview
  112. 8.19.3 AGC Biologics Plasmid DNA (pDNA) Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AGC Biologics Plasmid DNA (pDNA) Product Portfolio
  114. 8.19.5 AGC Biologics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst